In this study, we evaluated the expression of the immune–inflammatory mediators IL-1β, IL-6, IFN-β, and IFN-λ in postmortem lung specimens (i.e., the natural site of SARS-CoV-2 infection) of patients who died because of severe COVID-19 and control subjects. The gene discussed is IL1B; the disease is COVID-19.